|
US2020270697A1
|
|
Method for predicting organ transplant rejection using next-generation sequencing
|
|
KR20200102964A
|
|
Method for analyzing telomere length
|
|
KR20200137875A
|
|
Non-invasive prenatal testing method and devices based on double Z-score
|
|
CN111607650A
|
|
Method for identifying animal individuals by using single nucleotide polymorphism markers
|
|
KR20200028153A
|
|
Non-invasive prenatal testing method using cell free dna fragment derived maternal blood
|
|
KR20190141460A
|
|
Method and system for providing personalized aerobic capacity ability information based on genes
|
|
KR20190141463A
|
|
Method and system for providing personalized endurance training information based on genes
|
|
KR20190141459A
|
|
Method and system for providing personalized facial expression recognition ability information based on genes
|
|
KR20190141461A
|
|
Method and system for providing personalized autism information based on genes
|
|
KR20190141462A
|
|
Method and system for providing personalized ADHD risk information based on genes
|
|
KR20190140369A
|
|
Methods and systems for providing personalized psoriasis risk information for individuals based on genes
|
|
KR20190114351A
|
|
Methods for Identifying Microdeletion or Microamplification of Fetal Chromosomes Using Non-invasive Prenatal testing
|
|
KR20190102810A
|
|
Fetal gender determination method through non-invasive prenatal test
|
|
SG11201811031QA
|
|
Multiple z-score-based non-invasive prenatal testing method and apparatus
|
|
US2019032125A1
|
|
Method of detecting chromosomal abnormalities
|
|
US2019228131A1
|
|
Novel method capable of differentiating fetal sex and fetal sex chromosome abnormality on various platforms
|
|
KR20160122563A
|
|
Method for predicting transplantation rejection using next generation sequencing
|
